Procaps S.A. has raised funds
Procaps S.A. has closed a club deal bank facility in a transaction financed by Bancolombia S.A. and Banco Davivienda S.A. The funds will be designated for the refinancing of existing debts owed to current creditors. This strategic allocation will empower the company to navigate its growth plan with enhanced financial strength.
Procaps S.A. is a Colombian multinational firm, leader in the pharmaceutical market. The company develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and clinical solutions. Procaps distributes its products to 50 markets.
Oaklins’ team in Chile acted as the exclusive financial advisor to Procaps S.A. in this transaction.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Sun European Partners has secured financing to support its acquisition of B&H Worldwide
Sun European Partners has raised debt facilities to support its acquisition of B&H Worldwide.
Aprenda másInstituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Aprenda másRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Aprenda más